The role of Mediator and Little Elongation Complex in transcription termination.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
26 02 2020
Historique:
received: 02 02 2019
accepted: 08 02 2020
entrez: 28 2 2020
pubmed: 28 2 2020
medline: 1 5 2020
Statut: epublish

Résumé

Mediator is a coregulatory complex that regulates transcription of Pol II-dependent genes. Previously, we showed that human Mediator subunit MED26 plays a role in the recruitment of Super Elongation Complex (SEC) or Little Elongation Complex (LEC) to regulate the expression of certain genes. MED26 plays a role in recruiting SEC to protein-coding genes including c-myc and LEC to small nuclear RNA (snRNA) genes. However, how MED26 engages SEC or LEC to regulate distinct genes is unclear. Here, we provide evidence that MED26 recruits LEC to modulate transcription termination of non-polyadenylated transcripts including snRNAs and mRNAs encoding replication-dependent histone (RDH) at Cajal bodies. Our findings indicate that LEC recruited by MED26 promotes efficient transcription termination by Pol II through interaction with CBC-ARS2 and NELF/DSIF, and promotes 3' end processing by enhancing recruitment of Integrator or Heat Labile Factor to snRNA or RDH genes, respectively.

Identifiants

pubmed: 32102997
doi: 10.1038/s41467-020-14849-1
pii: 10.1038/s41467-020-14849-1
pmc: PMC7044329
doi:

Substances chimiques

MED26 protein, human 0
Mediator Complex 0
NSMF protein, human 0
Nuclear Proteins 0
RNA Cap-Binding Proteins 0
RNA, Small Nuclear 0
SRRT protein, human 0
SUPT5H protein, human 0
Transcription Factors 0
Transcriptional Elongation Factors 0
RNA Polymerase II EC 2.7.7.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1063

Références

Levine, M., Cattoglio, C. & Tjian, R. Looping back to leap forward: transcription enters a new era. Cell 157, 13–25 (2014).
pubmed: 24679523 pmcid: 4059561 doi: 10.1016/j.cell.2014.02.009
Richard, P. & Manley, J. L. Transcription termination by nuclear RNA polymerases. Genes Dev. 23, 1247–1269 (2009).
Guiro, J. & Murphy, S. Regulation of expression of human RNA polymerase II-transcribed snRNA genes. Open Biol 7, https://doi.org/10.1098/rsob.170073 (2017).
pubmed: 28615474 pmcid: 5493778 doi: 10.1098/rsob.170073
Gilmartin, G. M. Eukaryotic mRNA 3′ processing: a common means to different ends. Genes Dev. 19, 2517–2521 (2005).
pubmed: 16264187 doi: 10.1101/gad.1378105 pmcid: 16264187
Chen, J. & Wagner, E. J. snRNA 3′ end formation: the dawn of the Integrator complex. Biochem. Soc. Trans. 38, 1082–1087 (2010).
pubmed: 20659008 pmcid: 3969742 doi: 10.1042/BST0381082
Romeo, V. & Schumperli, D. Cycling in the nucleus: regulation of RNA 3′ processing and nuclear organization of replication-dependent histone genes. Curr. Opin. Cell Biol. 40, 23–31 (2016).
pubmed: 26895140 doi: 10.1016/j.ceb.2016.01.015 pmcid: 26895140
Dominski, Z. & Marzluff, W. F. Formation of the 3′ end of histone mRNA: getting closer to the end. Gene 396, 373–390 (2007).
pubmed: 17531405 pmcid: 2888136 doi: 10.1016/j.gene.2007.04.021
Yang, X. C. et al. A complex containing the CPSF73 endonuclease and other polyadenylation factors associates with U7 snRNP and is recruited to histone pre-mRNA for 3′-end processing. Mol. Cell. Biol. 33, 28–37 (2013).
pubmed: 23071092 pmcid: 3536302 doi: 10.1128/MCB.00653-12
Skrajna, A., Yang, X. C., Dadlez, M., Marzluff, W. F. & Dominski, Z. Protein composition of catalytically active U7-dependent processing complexes assembled on histone pre-mRNA containing biotin and a photo-cleavable linker. Nucleic Acids Res. 46, 4752–4770 (2018).
pubmed: 29529248 pmcid: 5961079 doi: 10.1093/nar/gky133
Dominski, Z., Yang, X. C. & Marzluff, W. F. The polyadenylation factor CPSF-73 is involved in histone-pre-mRNA processing. Cell 123, 37–48 (2005).
pubmed: 16213211 doi: 10.1016/j.cell.2005.08.002 pmcid: 16213211
Romeo, V., Griesbach, E. & Schumperli, D. CstF64: cell cycle regulation and functional role in 3′ end processing of replication-dependent histone mRNAs. Mol. Cell. Biol. 34, 4272–4284 (2014).
pubmed: 25266659 pmcid: 4248742 doi: 10.1128/MCB.00791-14
Lyons, S. M. et al. A subset of replication-dependent histone mRNAs are expressed as polyadenylated RNAs in terminally differentiated tissues. Nucleic Acids Res. 44, 9190–9205 (2016).
pubmed: 27402160 pmcid: 5100578 doi: 10.1093/nar/gkw418
Baillat, D. et al. Integrator, a multiprotein mediator of small nuclear RNA processing, associates with the C-terminal repeat of RNA polymerase II. Cell 123, 265–276 (2005).
pubmed: 16239144 doi: 10.1016/j.cell.2005.08.019 pmcid: 16239144
Yamamoto, J. et al. DSIF and NELF interact with Integrator to specify the correct post-transcriptional fate of snRNA genes. Nat. Commun. 5, 4263 (2014).
pubmed: 24968874 doi: 10.1038/ncomms5263 pmcid: 24968874
Andersen, P. R. et al. The human cap-binding complex is functionally connected to the nuclear RNA exosome. Nat. Struct. Mol. Biol. 20, 1367–1376 (2013).
pubmed: 24270879 pmcid: 3923317 doi: 10.1038/nsmb.2703
Hallais, M. et al. CBC-ARS2 stimulates 3′-end maturation of multiple RNA families and favors cap-proximal processing. Nat. Struct. Mol. Biol. 20, 1358–1366 (2013).
pubmed: 24270878 doi: 10.1038/nsmb.2720 pmcid: 24270878
Wada, T. et al. DSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologs. Genes Dev. 12, 343–356 (1998).
pubmed: 9450929 pmcid: 316480 doi: 10.1101/gad.12.3.343
Yamaguchi, Y. et al. NELF, a multisubunit complex containing RD, cooperates with DSIF to repress RNA polymerase II elongation. Cell 97, 41–51 (1999).
pubmed: 10199401 doi: 10.1016/S0092-8674(00)80713-8 pmcid: 10199401
Narita, T. et al. NELF interacts with CBC and participates in 3′ end processing of replication-dependent histone mRNAs. Mol. Cell 26, 349–365 (2007).
pubmed: 17499042 doi: 10.1016/j.molcel.2007.04.011 pmcid: 17499042
Conaway, R. C. & Conaway, J. W. The Mediator complex and transcription elongation. Biochim. Biophys. Acta 1829, 69–75 (2013).
pubmed: 22983086 doi: 10.1016/j.bbagrm.2012.08.017 pmcid: 22983086
Malik, S. Eukaryotic transcription regulation: getting to the heart of the matter: commentary on mediator architecture and RNA polymerase II function by Plaschka et al. J. Mol. Biol. 428, 2575–2580 (2016).
pubmed: 27056597 doi: 10.1016/j.jmb.2016.04.001 pmcid: 27056597
Allen, B. L. & Taatjes, D. J. The Mediator complex: a central integrator of transcription. Nat. Rev. Mol. Cell. Biol. 16, 155–166 (2015).
pubmed: 25693131 pmcid: 4963239 doi: 10.1038/nrm3951
Takahashi, H. et al. Human mediator subunit MED26 functions as a docking site for transcription elongation factors. Cell 146, 92–104 (2011).
pubmed: 21729782 pmcid: 3145325 doi: 10.1016/j.cell.2011.06.005
Takahashi, H. et al. MED26 regulates the transcription of snRNA genes through the recruitment of little elongation complex. Nat. Commun. 6, 5941 (2015).
pubmed: 25575120 pmcid: 4646223 doi: 10.1038/ncomms6941
Shilatifard, A., Lane, W. S., Jackson, K. W., Conaway, R. C. & Conaway, J. W. An RNA polymerase II elongation factor encoded by the human ELL gene. Science 271, 1873–1876 (1996).
pubmed: 8596958 doi: 10.1126/science.271.5257.1873 pmcid: 8596958
Kong, S. E., Banks, C. A., Shilatifard, A., Conaway, J. W. & Conaway, R. C. ELL-associated factors 1 and 2 are positive regulators of RNA polymerase II elongation factor ELL. Proc. Natl Acad. Sci. USA 102, 10094–10098 (2005).
pubmed: 16006523 doi: 10.1073/pnas.0503017102 pmcid: 16006523
Luo, Z., Lin, C. & Shilatifard, A. The super elongation complex (SEC) family in transcriptional control. Nat. Rev. Mol. Cell. Biol. 13, 543–547 (2012).
pubmed: 22895430 doi: 10.1038/nrm3417 pmcid: 22895430
He, N. et al. HIV-1 Tat and host AFF4 recruit two transcription elongation factors into a bifunctional complex for coordinated activation of HIV-1 transcription. Mol. Cell 38, 428–438 (2010).
pubmed: 20471948 pmcid: 3085314 doi: 10.1016/j.molcel.2010.04.013
Lin, C. et al. AFF4, a component of the ELL/P-TEFb elongation complex and a shared subunit of MLL chimeras, can link transcription elongation to leukemia. Mol. Cell 37, 429–437 (2010).
pubmed: 20159561 pmcid: 2872029 doi: 10.1016/j.molcel.2010.01.026
Sobhian, B. et al. HIV-1 Tat assembles a multifunctional transcription elongation complex and stably associates with the 7SK snRNP. Mol. Cell 38, 439–451 (2010).
pubmed: 20471949 pmcid: 3595998 doi: 10.1016/j.molcel.2010.04.012
Hu, D. et al. The little elongation complex functions at initiation and elongation phases of snRNA gene transcription. Mol. Cell 51, 493–505 (2013).
pubmed: 23932780 pmcid: 4104523 doi: 10.1016/j.molcel.2013.07.003
Smith, E. R. et al. The little elongation complex regulates small nuclear RNA transcription. Mol. Cell 44, 954–965 (2011).
pubmed: 22195968 pmcid: 3249835 doi: 10.1016/j.molcel.2011.12.008
Hutten, S., Chachami, G., Winter, U., Melchior, F. & Lamond, A. I. A role for the Cajal-body-associated SUMO isopeptidase USPL1 in snRNA transcription mediated by RNA polymerase II. J. Cell Sci. 127, 1065–1078 (2014).
pubmed: 24413172 pmcid: 3937775 doi: 10.1242/jcs.141788
Takata, H., Nishijima, H., Maeshima, K. & Shibahara, K. The integrator complex is required for integrity of Cajal bodies. J. Cell Sci. 125, 166–175 (2012).
pubmed: 22250197 doi: 10.1242/jcs.090837 pmcid: 22250197
Baird, T. D. et al. ICE1 promotes the link between splicing and nonsense-mediated mRNA decay. eLife 7, https://doi.org/10.7554/eLife.33178 (2018).
Kiss, T. Biogenesis of small nuclear RNPs. J. Cell Sci. 117, 5949–5951 (2004).
pubmed: 15564372 doi: 10.1242/jcs.01487
Bongiorno-Borbone, L. et al. FLASH and NPAT positive but not Coilin positive Cajal Bodies correlate with cell ploidy. Cell Cycle 7, 2357–2367 (2008).
pubmed: 18677100 doi: 10.4161/cc.6344 pmcid: 18677100
Wang, Q. et al. Cajal bodies are linked to genome conformation. Nat. Commun. 7, 10966 (2016).
pubmed: 26997247 pmcid: 4802181 doi: 10.1038/ncomms10966
Okada, Y. & Nakagawa, S. in Nuclear Bodies and Noncoding RNAs: Methods and Protocols (eds Nakagawa, S. & Hirose, T.) (Springer, New York, 2015).
Ezzeddine, N. et al. A subset of Drosophila integrator proteins is essential for efficient U7 snRNA and spliceosomal snRNA 3′-end formation. Mol. Cell. Biol. 31, 328–341 (2011).
pubmed: 21078872 doi: 10.1128/MCB.00943-10 pmcid: 21078872
de Vegvar, H. E., Lund, E. & Dahlberg, J. E. 3′ End formation of U1 snRNA precursors is coupled to transcription from snRNA promoters. Cell 47, 259–266 (1986).
pubmed: 3021336 doi: 10.1016/0092-8674(86)90448-4 pmcid: 3021336
Hernandez, N. & Weiner, A. M. Formation of the 3′ end of U1 snRNA requires compatible snRNA promoter elements. Cell 47, 249–258 (1986).
pubmed: 3768956 doi: 10.1016/0092-8674(86)90447-2 pmcid: 3768956
Brocato, J. et al. Arsenic induces polyadenylation of canonical histone mRNA by down-regulating stem-loop-binding protein gene expression. J. Biol. Chem. 289, 31751–31764 (2014).
pubmed: 25266719 pmcid: 4231654 doi: 10.1074/jbc.M114.591883
Brocato, J. et al. A potential new mechanism of arsenic carcinogenesis: depletion of stem-loop binding protein and increase in polyadenylated canonical histone H3.1 mRNA. Biol. Trace Elem. Res. 166, 72–81 (2015).
pubmed: 25893362 pmcid: 4470754 doi: 10.1007/s12011-015-0296-5
Costa, M. Review of arsenic toxicity, speciation and polyadenylation of canonical histones. Toxicol. Appl Pharm. 375, 1–4 (2019).
doi: 10.1016/j.taap.2019.05.006
Singh, R. K. et al. Excess histone levels mediate cytotoxicity via multiple mechanisms. Cell Cycle 9, 4236–4244 (2010).
pubmed: 20948314 pmcid: 3055206 doi: 10.4161/cc.9.20.13636
Marzluff, W. F. & Koreski, K. P. Birth and death of histone mRNAs. Trends Genet. 33, 745–759 (2017).
pubmed: 28867047 pmcid: 5645032 doi: 10.1016/j.tig.2017.07.014
Zheng, L. et al. Phosphorylation of stem-loop binding protein (SLBP) on two threonines triggers degradation of SLBP, the sole cell cycle-regulated factor required for regulation of histone mRNA processing, at the end of S phase. Mol. Cell. Biol. 23, 1590–1601 (2003).
pubmed: 12588979 pmcid: 151715 doi: 10.1128/MCB.23.5.1590-1601.2003
Mitrea, D. M. & Kriwacki, R. W. Phase separation in biology; functional organization of a higher order. Cell Commun. Signal. 14, 1 (2016).
pubmed: 26727894 pmcid: 4700675 doi: 10.1186/s12964-015-0125-7
Mukundan, B. & Ansari, A. Srb5/Med18-mediated termination of transcription is dependent on gene looping. J. Biol. Chem. 288, 11384–11394 (2013).
pubmed: 23476016 pmcid: 3630880 doi: 10.1074/jbc.M112.446773
Erb, M. A. et al. Transcription control by the ENL YEATS domain in acute leukaemia. Nature 543, 270–274 (2017).
pubmed: 28241139 pmcid: 5497220 doi: 10.1038/nature21688
Ran, F. A. et al. Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 8, 2281–2308 (2013).
pubmed: 24157548 pmcid: 3969860 doi: 10.1038/nprot.2013.143
Lens, Z. et al. Solution structure of the N-terminal domain of mediator subunit MED26 and molecular characterization of its interaction with EAF1 and TAF7. J. Mol. Biol. 429, 3043–3055 (2017).
pubmed: 28893534 doi: 10.1016/j.jmb.2017.09.001 pmcid: 28893534
Starck, S. R. et al. Leucine-tRNA initiates at CUG start codons for protein synthesis and presentation by MHC class I. Science 336, 1719–1723 (2012).
pubmed: 22745432 doi: 10.1126/science.1220270 pmcid: 22745432
Natsume, T., Kiyomitsu, T., Saga, Y. & Kanemaki, M. T. Rapid protein depletion in human cells by auxin-inducible degron tagging with short homology donors. Cell Rep. 15, 210–218 (2016).
pubmed: 27052166 doi: 10.1016/j.celrep.2016.03.001 pmcid: 27052166
Dignam, J. D., Martin, P. L., Shastry, B. S. & Roeder, R. G. Eukaryotic gene transcription with purified components. Methods Enzymol. 101, 582–598 (1983).
pubmed: 6888276 doi: 10.1016/0076-6879(83)01039-3 pmcid: 6888276
Florens, L. & Washburn, M. P. Proteomic analysis by multidimensional protein identification technology. Methods Mol. Biol. 328, 159–175 (2006).
pubmed: 16785648 pmcid: 16785648
Washburn, M. P., Wolters, D. & Yates, J. R. 3rd Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat. Biotechnol. 19, 242–247 (2001).
pubmed: 11231557 doi: 10.1038/85686 pmcid: 11231557
Eng, J. K., McCormack, A. L. & Yates, J. R. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J. Am. Soc. Mass Spectrom. 5, 976–989 (1994).
pubmed: 24226387 doi: 10.1016/1044-0305(94)80016-2 pmcid: 24226387
Xu, T. et al. ProLuCID: an improved SEQUEST-like algorithm with enhanced sensitivity and specificity. J. Proteom. 129, 16–24 (2015).
doi: 10.1016/j.jprot.2015.07.001
Tabb, D. L., McDonald, W. H. & Yates, J. R. 3rd DTASelect and Contrast: tools for assembling and comparing protein identifications from shotgun proteomics. J. Proteome Res. 1, 21–26 (2002).
pubmed: 12643522 pmcid: 2811961 doi: 10.1021/pr015504q
Paoletti, A. C. & Washburn, M. P. Quantitation in proteomic experiments utilizing mass spectrometry. Biotechnol. Genet. Eng. Rev. 22, 1–19 (2006).
pubmed: 18476323 doi: 10.1080/02648725.2006.10648062 pmcid: 18476323
Zhang, Y., Wen, Z., Washburn, M. P. & Florens, L. Refinements to label free proteome quantitation: how to deal with peptides shared by multiple proteins. Anal. Chem. 82, 2272–2281 (2010).
pubmed: 20166708 doi: 10.1021/ac9023999 pmcid: 20166708
Zybailov, B. et al. Statistical analysis of membrane proteome expression changes in Saccharomyces cerevisiae. J. Proteome Res. 5, 2339–2347 (2006).
pubmed: 16944946 doi: 10.1021/pr060161n pmcid: 16944946
Mahat, D. B. et al. Base-pair-resolution genome-wide mapping of active RNA polymerases using precision nuclear run-on (PRO-seq). Nat. Protoc. 11, 1455–1476 (2016).
pubmed: 27442863 pmcid: 5502525 doi: 10.1038/nprot.2016.086
Kwak, H., Fuda, N. J., Core, L. J. & Lis, J. T. Precise maps of RNA polymerase reveal how promoters direct initiation and pausing. Science 339, 950–953 (2013).
pubmed: 23430654 pmcid: 3974810 doi: 10.1126/science.1229386

Auteurs

Hidehisa Takahashi (H)

Department of Molecular Biology, Yokohama City University Graduate School of Medical Science, Fukuura 3-9, Kanazawa-ku, Yokohama, Kanagawa, 216-0004, Japan. hide0213@yokohama-cu.ac.jp.

Amol Ranjan (A)

Stowers Institute for Medical Research, 1000E 50th Street, Kansas City, MO, 64110, USA.

Shiyuan Chen (S)

Stowers Institute for Medical Research, 1000E 50th Street, Kansas City, MO, 64110, USA.

Hidefumi Suzuki (H)

Department of Molecular Biology, Yokohama City University Graduate School of Medical Science, Fukuura 3-9, Kanazawa-ku, Yokohama, Kanagawa, 216-0004, Japan.

Mio Shibata (M)

Department of Biochemistry, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Kita 15, Nishi 7, Kita-ku, Sapporo, Hokkaido, 060-8638, Japan.

Tomonori Hirose (T)

Department of Molecular Biology, Yokohama City University Graduate School of Medical Science, Fukuura 3-9, Kanazawa-ku, Yokohama, Kanagawa, 216-0004, Japan.

Hiroko Hirose (H)

Department of Molecular Biology, Yokohama City University Graduate School of Medical Science, Fukuura 3-9, Kanazawa-ku, Yokohama, Kanagawa, 216-0004, Japan.

Kazunori Sasaki (K)

Department of Molecular Biology, Yokohama City University Graduate School of Medical Science, Fukuura 3-9, Kanazawa-ku, Yokohama, Kanagawa, 216-0004, Japan.

Ryota Abe (R)

Department of Molecular Biology, Yokohama City University Graduate School of Medical Science, Fukuura 3-9, Kanazawa-ku, Yokohama, Kanagawa, 216-0004, Japan.

Kai Chen (K)

Stowers Institute for Medical Research, 1000E 50th Street, Kansas City, MO, 64110, USA.

Yanfeng He (Y)

Stowers Institute for Medical Research, 1000E 50th Street, Kansas City, MO, 64110, USA.

Ying Zhang (Y)

Stowers Institute for Medical Research, 1000E 50th Street, Kansas City, MO, 64110, USA.

Ichigaku Takigawa (I)

Graduate School of Information Science and Technology, Hokkaido University, Kita 14, Nishi 9, Kita-ku, Sapporo, Hokkaido, 060-0814, Japan.

Tadasuke Tsukiyama (T)

Department of Biochemistry, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Kita 15, Nishi 7, Kita-ku, Sapporo, Hokkaido, 060-8638, Japan.

Masashi Watanabe (M)

Department of Biochemistry, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Kita 15, Nishi 7, Kita-ku, Sapporo, Hokkaido, 060-8638, Japan.

Satoshi Fujii (S)

Department of Bioscience and Bioinformatics, Kyushu Institute of Technology, Iizuka, Fukuoka, 820-8502, Japan.

Midori Iida (M)

Department of Bioscience and Bioinformatics, Kyushu Institute of Technology, Iizuka, Fukuoka, 820-8502, Japan.

Junichi Yamamoto (J)

Department of Nanoparticle Translational Research Tokyo Medical University, 6-7-1, Nishi-Shinjuku, Tokyo, Shinjuku-ku, 160-0023, Japan.

Yuki Yamaguchi (Y)

Graduate School of Bioscience and Biotechnology, Tokyo Institute of Technology, Yokohama, Kanagawa, 226-8501, Japan.

Yutaka Suzuki (Y)

Laboratory of Systems Genomics, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, 5-1-5, Kashiwanoha, Kashiwa, Chiba, 277-8562, Japan.

Masaki Matsumoto (M)

Department of Molecular and Cellular Biology, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, Fukuoka, 812-8582, Japan.
Division of Proteomics, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, Fukuoka, 812-8582, Japan.

Keiichi I Nakayama (KI)

Department of Molecular and Cellular Biology, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, Fukuoka, 812-8582, Japan.
Division of Proteomics, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, Fukuoka, 812-8582, Japan.

Michael P Washburn (MP)

Stowers Institute for Medical Research, 1000E 50th Street, Kansas City, MO, 64110, USA.
Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, 66160, USA.

Anita Saraf (A)

Stowers Institute for Medical Research, 1000E 50th Street, Kansas City, MO, 64110, USA.

Laurence Florens (L)

Stowers Institute for Medical Research, 1000E 50th Street, Kansas City, MO, 64110, USA.

Shigeo Sato (S)

Stowers Institute for Medical Research, 1000E 50th Street, Kansas City, MO, 64110, USA.

Chieri Tomomori-Sato (C)

Stowers Institute for Medical Research, 1000E 50th Street, Kansas City, MO, 64110, USA.

Ronald C Conaway (RC)

Stowers Institute for Medical Research, 1000E 50th Street, Kansas City, MO, 64110, USA.
Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS, 66160, USA.

Joan W Conaway (JW)

Stowers Institute for Medical Research, 1000E 50th Street, Kansas City, MO, 64110, USA. JLC@stowers.org.
Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS, 66160, USA. JLC@stowers.org.

Shigetsugu Hatakeyama (S)

Department of Biochemistry, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Kita 15, Nishi 7, Kita-ku, Sapporo, Hokkaido, 060-8638, Japan. hatas@med.hokudai.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH